Sangamo Therapeutics, Inc. (FRA:GBY)

Sangamo Therapeutics Revenue

Sangamo Therapeutics had revenue of $581.00K USD in the quarter ending September 30, 2025, a decrease of -98.82%. This brings the company's revenue in the last twelve months to $32.88M, down -37.13% year-over-year. In the year 2024, Sangamo Therapeutics had annual revenue of $57.80M, down -67.20%.

• Revenue (ttm): $32.88M
• Revenue Growth: -37.13%
• P/S Ratio: 4.58
• Revenue / Employee: $179.64K
• Employees: 183
• Market Cap: 128.19M EUR

Revenue Chart

* This company reports financials in USD.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	57.80M	-118.43M	-67.20%
Dec 31, 2023	176.23M	64.93M	58.34%
Dec 31, 2022	111.30M	598.00K	0.54%
Dec 31, 2021	110.70M	-7.49M	-6.34%
Dec 31, 2020	118.19M	15.76M	15.39%
Dec 31, 2019	102.43M	17.98M	21.29%
Dec 31, 2018	84.45M	47.89M	130.95%
Dec 31, 2017	36.57M	17.18M	88.60%
Dec 31, 2016	19.39M	-20.15M	-50.96%
Dec 31, 2015	39.54M	-6.33M	-13.80%
Dec 31, 2014	45.87M	21.74M	90.07%
Dec 31, 2013	24.13M	2.48M	11.44%
Dec 31, 2012	21.66M	11.34M	109.86%
Dec 31, 2011	10.32M	-10.49M	-50.40%
Dec 31, 2010	20.81M	-1.38M	-6.23%
Dec 31, 2009	22.19M	6.00M	37.08%
Dec 31, 2008	16.19M	7.09M	77.91%
Dec 31, 2007	9.10M	1.21M	15.38%
Dec 31, 2006	7.89M	5.40M	217.43%
Dec 31, 2005	2.48M	-	-